<SEC-DOCUMENT>0001193125-11-202602.txt : 20110926
<SEC-HEADER>0001193125-11-202602.hdr.sgml : 20110926
<ACCEPTANCE-DATETIME>20110729144558
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-11-202602
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20110729

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IRIDEX CORP
		CENTRAL INDEX KEY:			0001006045
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				770210467
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1230

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		1212 TERRA BELLA AVE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		6509404700

	MAIL ADDRESS:	
		STREET 1:		1212 TERRA BELLA AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>Correspondence Letter</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px">


<IMG SRC="g214626gra7.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">1212 Terra Bella Avenue </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mountain View, CA 94043-1824 USA </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">July&nbsp;28, 2011 </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I><U>Via EDGAR and Overnight Courier </U></I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Paul&nbsp;A. Belvin </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Cecilia Blye, Chief Office of Global Security Risk
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Amanda Ravitz, Assistant Director, Division of Corporation Finance </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">United States Securities and Exchange Commission </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">100 F Street, N.E. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Washington, D.C. 20549 </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Re:</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IRIDEX Corporation </B></FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 10-K for the Fiscal Year Ended January&nbsp;1, 2011 </B></FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed March&nbsp;24, 2011 </B></FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;File No. 000-27598 </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dear Mr.&nbsp;Belvin and Ms.&nbsp;Blye: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On behalf of IRIDEX Corporation
(&#147;<B>we</B>,&#148; the &#147;<B>Company</B>,&#148; or &#147;<B>IRIDEX</B>&#148;), we submit this letter in response to comments from the staff of the Securities and Exchange Commission (the &#147;<B>Staff</B>&#148;) received by letter dated
June&nbsp;29, 2011, relating to the Company&#146;s Form&nbsp;10-K for the fiscal year ended January&nbsp;1, 2011 (the &#147;<B>Form&nbsp;10-K</B>&#148;) filed on March&nbsp;24, 2011. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In this letter, we have recited the comments from the Staff in italicized type and have followed each comment with the Company&#146;s
response. Capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Form&nbsp;10-K. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B>1.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Please update us on your contacts with Iran, Syria and Sudan, whether through distributors, resellers, affiliates, subsidiaries, or other direct or indirect
arrangements, since your letters to us of February&nbsp;28, 2007,&nbsp;April&nbsp;30, 2007,&nbsp;August&nbsp;2, 2007 and October&nbsp;17, 2007. Describe to us the nature and extent of any past, current and anticipated contacts with those countries
since your letters, including any products or services you have provided or anticipate providing, directly or indirectly, to the referenced countries, and any agreements, commercial arrangements, or other contacts you have had, or intend to have,
directly or indirectly, with the governments or entities controlled by the governments of those countries. </I></B></FONT></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">United States Securities and Exchange Commission </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">July 28, 2011 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"> Page
 2
 </FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Response</U>: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company is a leading worldwide provider of therapeutic based laser systems and delivery devices used to treat eye diseases in ophthalmology and skin conditions in dermatology. We sell internationally
through approximately 100 independent distributors into 107 countries. Our customers are doctors, hospitals or healthcare practices. The Company has only engaged in the sale of Ophthalmology products and not Aesthetics products to Iran, Syria and
Sudan. Our products are classified by the U.S. Department of Commerce as EAR99 (EAR99 items generally consist of low-technology consumer goods) and we obtain export licenses for any sales to Iran, Syria and Sudan prior to completing any such sales.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Iran</U>: We have a distribution agreement with Iran Memco, based in Iran, who operates as our distributor for ophthalmology products in
Iran. We have been working with Iran Memco since 2007. Our sales to Iran are as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="54%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:15pt"><FONT STYLE="font-family:Times New Roman" SIZE="1">Year</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:16pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1">Sales</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:37pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1">Description</FONT></P></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2008</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">101,480</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Qty 2: SLx Laser System; Qty&nbsp;2:&nbsp;GLx&nbsp;Laser&nbsp;System</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">94,630</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Qty&nbsp;1:&nbsp;IQ810&nbsp;Laser&nbsp;System;&nbsp;Qty&nbsp;77&nbsp;boxes:&nbsp;EndoProbes</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">YTD 2011</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We anticipate future business dealings to follow this pattern and to reflect this magnitude. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Syria</U>: We have a working relationship but no formal distributor agreement with Pioneers for Medical Equipment, based in Syria, who operates as our
distributor for ophthalmology products in Syria. We have been working with Pioneers for Medical Equipment since 2006. Our sales to Syria are as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="54%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:15pt"><FONT STYLE="font-family:Times New Roman" SIZE="1">Year</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:16pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1">Sales</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:37pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1">Description</FONT></P></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2008</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Qty 1: SLx Laser System</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,191</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Qty 2: SL Laser System</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,090</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Qty 1: SL Laser System; Qty 7 boxes: EndoProbes</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">YTD 2011</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66,723</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Qty 1: IQ577 Laser System; Qty 1: IQ810 Laser Sytem; Qty 6 boxes: EndoProbes</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We anticipate future business dealings to follow this pattern and to reflect this magnitude. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Sudan</U>: We do not have a distributor covering Sudan and have made no sales into Sudan during the last three fiscal years or during the subsequent
interim period. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="92%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:15pt"><FONT STYLE="font-family:Times New Roman" SIZE="1">Year</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1">Sales</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2008</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">YTD 2011</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">United States Securities and Exchange Commission </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">July 28, 2011 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"> Page
 3
 </FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">CTEQ Ltd, based in the United Kingdom, has approached us to act as a distributor for the sale of $67,500
ophthalmology products (SLx and GLx Symphony system) to a doctor in Sudan. We have submitted an application for export but due to the Sudan license application backlog at OFAC we do not anticipate receiving approval in 2011 and, when and if we
receive such an export license, we do not anticipate that sales into Sudan will be material to the Company. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B>2.</B><B><I></I></B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Please discuss the materiality of your contacts with Iran, Syria or Sudan described in response to the foregoing comment and whether those contacts constitute a
material investment risk for you security holders. You should address materiality in quantitative terms, including the approximate dollar amounts of any associated revenues, assets, and liabilities for the last three fiscal years and the subsequent
interim period. Also, address materiality in terms of qualitative factors that a reasonable investor would deem important in making an investment decision, including the potential impact of corporate activities upon a company&#146;s reputation and
share value. Various state and municipal governments, universities, and other investors have proposed or adopted divestment or similar initiatives regarding investment in companies that do business with U.S.-designated state sponsors of terrorism.
Your materiality analysis should address the potential impact of the investor sentiment evidenced by such actions directed toward companies that have operations associated with Iran, Syria and Sudan. </I></B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our contacts with Iran, Syria or Sudan are not material in qualitative or quantitative terms and we do not consider these contacts a
material investment risk for our security holders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our revenues for 2008, 2009, 2010 and the first quarter 2011 were
$48,528,000, $43,212,000, $43,694,000 and $11,212,000, respectively. Aggregate sales to Iran, Syria and Sudan expressed in terms of a percentage of overall revenues were 0.26%, 0.07%, 0.27% and 0.60%, respectively, during 2008, 2009, 2010 and the
first quarter 2011. In quantitative terms the contacts with Iran, Syria and Sudan are not material to the Company. Apart from the sales described above, the Company does not own any assets or liabilities associated with these countries. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our sales in these countries are to doctors, hospitals or healthcare practices and our products have no material non-medical use. We sell
medical devices that help save people&#146;s sight. We obtain prior U.S. government approval for all of our sales into Iran, Syria and Sudan in the form of an export license prior to completing any particular sale. Therefore we do not consider these
corporate activities as having a negative impact on the company&#146;s reputation and or share value and we do not consider these contacts to be qualitatively material to investors wishing to avoid investment in companies that do business with
U.S.-designated state sponsors of terrorism. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with IRIDEX&#146;s responses to the Staff&#146;s comments, we
acknowledge that we are responsible for the adequacy and accuracy of the disclosure in our filings with the Securities and Exchange Commission, Staff comments or changes to disclosure in response to Staff comments do not foreclose the Securities and
Exchange Commission from taking any action with respect to such filings, and we may not assert Staff comments as a defense in any proceeding initiated by the Securities and Exchange Commission or any person under the federal securities laws of the
United States. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">United States Securities and Exchange Commission </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">July 28, 2011 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"> Page
 4
 </FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Please acknowledge receipt of this letter by stamping the enclosed duplicate of this
letter and returning it to the undersigned in the envelope provided. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We would like to discuss these comments and responses at
your earliest convenience. David J. Segre and Todd C. Carpenter, Esq. of Wilson Sonsini Goodrich&nbsp;&amp; Rosati, Professional Corporation can be reached at (650)&nbsp;493-9300, and I may be reached at (650)&nbsp;962-8848 ext. 3016. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">Sincerely,</FONT></TD></TR>


<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/James H. Mackaness</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">James H. Mackaness</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">IRIDEX Corporation</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer</FONT></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">cc:</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">David J. Segre </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Todd C. Carpenter </FONT></TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g214626gra7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g214626gra7.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`E@"=`P$1``(1`0,1`?_$`-0```$$`@,!`0``````
M``````D`"`H+`P<"!08$`0$!``(!!0$```````````````<(!@$#!`4)`A``
M``8"``0"!@8$"`8."P```0(#!`4&!P@`$1()$Q4A%!87&`HQL2(R<B-!D5(:
M820EUI=8&3E1H29VMWCP<8'!T;-TM3:V-W<XN$(S4S1D18:G2&@J$0`!`P,"
M!`0#!`8&"`<````!``(#$00%(08Q01('46$B$W$R"(%"(Q3PD:&Q8A7!T5)R
MLA;A@C-C)'0V%_&B0U.S-#?_V@`,`P$``A$#$0`_`)^2B@D$```'T<_\8_\`
M!P1</'']D/UCP1+QQ_9#]8\$2\<?V0_6/!$O'']D/UCP1+QQ_9#]8\$7X+GI
MY=72',>0<S<N8_X`Y_IX(M!Y^VKUZU:KK*U;"9FQKB"%E%3MX96]6J.AY"Q.
MR"F'EU4@#*J6&VRAQ5*!6L8U=N!Z@^QP1,:O'=>A6-04OF+=5]AKE0/"D7#;
M+F:$<=Z387=-&<7+R+:3;W';V[XHLCZ$?^6$Z'C*!=HB@Y*J43])R`1,FL7?
MMKT9<'M;E,I=I?%Z<9"1CEVG=.Y9(9#D5IR0YNSQZ"^'-:K+7TFC:+704%7U
MU4PJB8G2'(!X(NVH'?>B;1,66)86?M?Y7+#!&/(Y;%?<]K%0E)F/<E32>M&$
M%GS!^,VB]@+(G%!H@:21;N!`#*+H$,!P(GRP7=-H48R6DL^Z^['ZZ5E%1PF.
M6)BE0F<M?#`E)24<BNOG+5ZT9IIT"U4&-$ZBLR,4DW\0I53%'GR(G^8OS%B_
M-=-89"Q!D6AY2H\GX@,;=CRUPMOK;@Z1A*L@67@WCUH5TV-]E9(QBJI'`2G*
M4P"`$6Q`7$?2``(#Z0$!^G@B7CC^R'ZQX(EXX_LA^L>")>./[(?K'@B7CC^R
M'ZQX(EXX_LA^L>"+]\8>0CTAZ!`/U@;_`(."+BO]\/PA]8\$6'@B7!$N")<$
M772\O$U^)E)^?E(Z#@H..?3$W-S#UM&Q$/$1C55])2LI(O%$6<?'1[)`ZRZZ
MIR)I)$,8P@`"/!%&VWO[W%7K.+WE^QAEF&UBU><K/HZ#W,N%.8WS,&Q#YH0A
MU8GMW:P3RS4^6XMX<Z;<<G6LC2@L^I=5LG)`B53@BAE9*[S.R^8,FR*G;NPS
M-XVR!*1JM=LVX>7I!AL=OG>8ARFHDJ]LN?KO%'I.`H9T*QETX:A1==8QP])$
M%C$23Y9%MW:N?W5?-QV#M9;B[<:4:/0/,RGT#[5TV<W!A=MVAOLW<Q6]N!IU
M'4_`<3Y`!-+D]*-G=@II6Y[4[(6FW6:35,Y>N+5:[5F"V&676=.EC*SEHF19
MH.!<O%!_*46)S54Y#Z?38_;WTH;FNVB7=-[!C6$Z,:/><[R#FD-!/`$Z`\=%
M!.9^I';EMU1[=L[C(R`?,3[#6^+G!P+B!QT%2!HO;1?;*P&2.E7KBT9;L3.&
M,X7F9V)0:*0M=;M3,D')+!)Q-3E(F%*U</D044>.$.DZY"B`"8O/)AV)[*XG
M(,P6XMQ219N5_0R-TL;'%YX-#1%(":\NH?%8T[O%W>R5G_-L'M]K\0UM72-9
M(]@;Q+BYTD9`IQHTZ+G:NUSAR+DFD$O8\N4.QN&:SQI"W.-:QLI(H'016;O6
MT)9*S7I%VQ336(IU(E,55)0#`<H"4P[&/[&=E]UF.':^X;ALP@D,@)CE>96N
MZ0(XPR,D'F*UIK5;USWG[H;<_,.W/@*PQS,#71LD#?;<VI<3U.J:_8NEH6O&
M]>G-@]O=+MI;O3IQJ/B)EH=VL.+9-XBFJJHFTE(E*26JD^V,503*-W8F15$Y
M@$@]0B;#MS?2UOC$6_OX=]O?<3T=8CN'-Y%L)ZJT&KO5H`2LLV_]1FS,HYD&
M49+8RGYGO^1I\^>IT">/K[WM\B8TS7%2V\V,[MB'-R#J,9R&ZVG,7#X(V)%!
MJ=%$SO/6%$X\NM6YE.641!5ZTGX1K)."'4]6DRG$G*O&7P&8V_=.LLU:S073
M3P<"/Z%.N/R6-S%HV^Q-Q%/:.X.:0:_J/^GR"G$:,]X2IY8J>.S9UM^+[31L
MF3\;1<-[MX40F8W7C*5[?IH"PQ-F>C6-5W>--=DER.$P/6;6=2!DUSE+$3#E
M15-H3J!1PZF_*N:06GI=\R.BFH!_LB)?$*'YA`Y_9,'H,'I`!Y`;T<:(LG!$
MN")<$2X(N0?<-^(OU'X(LB_WP_"'UCP18>")<$2X(N)SD3*)SF*0A0$QCF$"
ME*4H"8QC&'D!2%*`B(CZ``.8^C@BA1=ZGO`T>>QFK9[(DVL>DKRUV.L:Y8$8
MS:K5[W/,FXXEC1U@RAF"2AG3>6J_;@P_<F7JYHYL<K_*\VU\`#IQ!3'-KP(;
M0DD<EH0210@!1%X>@;'=R#*[W:?<Z]6*8BYQBQ;5XH`QA`>UB.76)!T?'%<C
MT48G'&**VU$R+%HQ:MVZ20@5N01,9;BQ_:'L->[QFBS&[6R6.V'?[.M0ZZ=7
MY&D:L%/O?^*@[N?WDQ^T628C".;-N!H/N'YFVK=?6X'YR.(9^OP1.JG5*CC^
M(AZ;2Z\U@X\ZI6$)7*W%N7LC,/@3`128QD8W>S5CEEB!UGZ$W#@X<Q'T!Z+O
ML;LOMKM^@-M88KA[)`K\:GU$\^.JJ+.[=^_LS^8Z;C(3DC34L'@>D>EH_8$0
M+074A+;O<NIZZ9"96.O52IHV.]Y]K;Q"9I=V;4ZD>7M5*.[9O"0]IK+JYV>>
MCF"ZQ2(."1BCHR)RG$B@0MWP[LXVQ[?V\FP[MD\UV3&_HH"UK@0XTUH>DFG!
M2KVE[;7]SO2>/>5H^`VO2]@?5P>X.J*'A04KS'D>"E&=W/'E$Q/VA=JJ'C*G
MUR@TFLXRJL77ZG48AE7Z]#Q[?)%&32:L(J,1;,T"`3Z1`G6<1$3"(B(C3#MZ
M#==P,6ZY)D<^]B!+C6OJ\ZJU&^VANR<BR/T-;9R4Z?333RHGGR^`\-;&:S4?
M'&;\<5G)5/E\5TI!:,L4<@Z=1ZJE2C4R2M;EA*65K-A8^*91J_8+-W;98`.F
MH4P<^,,M;R[M;AMS:2.BGC/6'-)!KJXZC7E^@63NM8+N,VMPUKH7^@]6M0&@
MBOCJ2H'.<L#V7!VRN8M7V+>W9$LV*KA9HN(+$5:>L%QLN/8]DWLU<O$E7Z[&
MR+\$5J1*-%I!ZFEZD#HJQBG`!`./2GMQW9P5UVXQVY]QY&.VR%P\P.!H)&>W
MIU?VJ/I0^15#M]]M,ZS?-Y;;>QYN+(CK:"*QZZD5.FE#TZUT":9D/&6.<S5U
M6OWF`862,$SM!NLHF9"5AGB"IVKL8J0`A'T+*M'"1DU"_9,10@D5)Z!#C/\`
M.[6VMW'PA!AAR5C*`?S$;@Q\?@[J;J:<2.?-8AA]P[FV%E_=BDGL;R($.MG@
MNC>WGZ7::<OV(=53MFQ?::RK+Y`Q(M#94P%EB!=8]RMB_)T*K9,0Y>HTJ10K
MS&.;J:V=MF[A5(OYD3,-E&[UJX*"K59,X*I'\^^ZG:#)[`NW7&,+[[;KY`T3
M`?(\U(:1Y`'4\5=KMOW/PV_[`-+A!F6,U8[2M*`EH\/'P^"G@]F_NA42X4#$
M%25RK;,DZ\9VLJU)P-=<E6->[90U#S5Y/YV^T)VHOL@BWDY\7(H.E\07N6$%
M;C$$")7,,@V;F=PQ2@H?FY_U*3^DL'2XU?\`T*3X',``!^D`]/HY>G]/H_1Z
M>-%HOW@B7!$N"+D'W#?B+]1^"+(O]\/PA]8\$6'@B7!$N"()_>-V'AZ_C1YK
M;(7%]1\=63&=WSSNUD&NRZT-;<;:,XQ,BTNL#29)L=-9EE7:"\NF..ZN7F)S
MI/Y=PD7Q&11*15N;^SW'NJ;DW;8[*=::5?#=/2@ZG1L7095FE4QSBJEL@A,.
M:_4U%$Q$VM>J58;)F>BB!#+'\98P`=US"<>Q_;1V^MP&^RE(]M60ZY7NJ&RT
MU]JHIQUK0U41]X>X3=CX!L.-K)N.\/1$P"ICKH9O@.5=*\M$45F]KS$C2'8.
MH5DFS30CF42T<,D"LT6Z946[%NP34`S=-ND4"D3*4.0```''HW;S8RVB&.M?
M1;NC:&L$D5&M`'2&@U+:"@J*.\3543FMLA/<?G+ISGO#BYSG12DN<35Q<[[P
M)KH:M\!128?EU<14.2F]I<Z2K!&2R;77V/L45IZZ15.:I4F0@WMNF5(%4Z)4
M6#VY3C@J4@=$_CJ(Q#<I^E/I*:AWU59"]N=[002R/-A_+XW]-:-ZR2"Z@H:Z
M`>''Q5R_IXM;:#:LUQ&UGYTW[V%W3J&B@#==*4U\J^*D=/\`"&-'N::_L(:I
MQY,O5_'MCQ0VN[<RC>6<X]M$_6;1)5J5%,Q4Y=DA.U)FX9^L`<[(XK>")`76
M`]927%O14]%:TJ:5^"GZOJZZ#K\:"J8;WL_[K'<;_,&M_P"DRC\9MVU_Z^Q'
M_/1?XEB._/\`HW)_\G)_A1!<0`!L3XM`0Y@.-:*`A_\`2L3Q@;"0ZHXT'[BL
MJ;Q_US_@:OBJ>%\;47(64<I5:HQ$7?LTR=<E<FW!%`HV.SK5&JQ%,J[)[+&#
MUT86!@H5)-JR*?U=%5198I?$64,.\YSG4:YSNBO"IH*^`X`GQ`JMRC2YSZ#K
M(U-!734*([WY,-X^QCN74+M186/KDCG'$;NY9+CXEL@S8S=VJMN5KI;Z[;H]
M(#8[!!OD&LBXY%%WY<BJ?J5\4YKI_23?W]U:Y7$O=*ZRB<US1UT#:$UU<::T
MX'BJG_4Q9V,9Q=[[)_-R.>TNC;5[M`6UH.`)0+IMI3KI$253FP@+)#SS95A)
M0;ETS=IR#90H]9/`(L98JJ0@!R*$`%$CE`Y1`0YA;'(VF$W!:/Q5ZZV-O+Z'
M-EDCZ=0=1T$'K\#X55=+)V?P=XS+8V+(0W<7J:\1TJ`15I]--?,(=NMV66G;
M)VTM&-,R(62X:.;45MGCS/D##+JL[`ZQ@YGTY2I92I+@HG3BL]:QWU!O9*U(
MI?QMN\8B5(Z/KAC%\Q^ZW;V^[<;JGPTOJQTCS)"\:M+3P`=SI\?BO0+M[O6W
MWUMJ#*QAK+EC0R5E?4UXXDCD#RX>"M#.VWL'<<QX6DL>YAN$#>L_:[2L1CC)
MEWKIBA"Y>K4S6HNZX/V.K:?/F-8V!P].14\0Q0\)*6/(M"CS:F`(R6<(A_!$
MN")<$7(/N&_$7ZC\$61?[X?A#ZQX(L/!$N"+"OS!,>1_#'F7\P1Y%('/TG/S
MY!T%#TFY^@`X(JS_`.8*W5G+KBVR(5F1F%)3N3;)V?(A'"3QX#1;1O2>Q2NO
M^J=)8LEDS$]GLI9B:V_(0@B9,%UG#=50IBG2-QN6\;YKF-D8ZC(\,`_BJ/ZU
M\R.:QCG//2UC.LGRHFUZ^8BJ&&,0X_I=KB)6;@&#VMVC+,=7GCF+L5G;*R\5
M-7Z/B7[%=N[0EE8-!9FQZ5.D3HI%.!RB8AO1W']O<C@NRMSLW#/=%G?R;;@2
ML]+W74C1.8NH:U#/13PT5%[O?-EFN[MKN3(,8^P%TZV+'CJ8VU:XM9+0Z:CU
MUHI[E/Q;C*HXCK)9;6_`FW&G]TJL++U3(F*<!XY3R1$T"P-F\C&/;QA"N5A&
M'R9%MR/$W*TK2B-I4ANHQH#Q$SK&\[9<ADS.Z2::<7(<:DO=U!U=16M00>.J
MO&R&T=$&PLC_`"Q:.D`#IZ3PH*:BE*>2U;J9K=1M1=ID,SZ;V(M]T;W,A8['
M-OI=8D9"WIZ^9JII)BQX]L[&0<NI&:9XSL;5W+5^3BY0`D*I-/629A*R.*3'
MFYW=&9W2RT=GI7SWEM'[;GO)+RROI:2>('*O(KK\-@,9@9)!C8H[>VED,CF,
M'2TO-*OH/O']/%'/$>0"/(>0`(\@`1'T!SY``<Q$?X/IXZ/]Z[=!=[MV<,3Y
M<[9W<2K>,[S!7:8PVSKV.<HH5YP>0;4J_)73&\ZZILO)))>5FLL;%RS=1XT0
M6668F5*FX!)3['&9]O3+_G?%4'23>QT(^*Q7?9#MG9(`"OY23]R(+CS..(ZN
M37G!UDR!68++>1L*0=KH%"EY`D=/W6!JU<@$+,\JR+L$4)U:`%XD=VU;**.T
M43@J9($OM\85T2ND>6-_"8UI)\*DC_0LH'M@T<:/+C0>/I"<RFL51,B@`8"G
M$`*!@`!YB8"@(ASY`'/T^G]'&I:7"@T*^P::J/[<-<M;-A=A;MO]OC).K!CJ
MP2L=B?2_6F7BK04MNQMBTSU`MNF<2LX_WBY8NV2\@2LQ+1M:38F8-(15BN\:
M+++B*'?V.Z\UBL=+AL7/+;VMPX.E]MQ;[A;\O400:#P_6NGO,#BLC>17]_%'
M-/`TB/K:'='5\W37@?/]2]+N_2,>OM3,R9+S=KQBK6[62H4LRK2@H8SQ>_VB
MRE,O4P@Z14X>8A8^6J&O3NT3\HQC601HS=I:BN90CF(53^Q\X2/-97-6N/QT
MDQO9[AC00YU:D\>-5N967'V>,GNKYL?Y2*)SCU`=(`'GHH&&Y&%PR'KDX2!`
M7]MQ;$M[1#.%'"KYTX\IBTF]I9G>N#"Y>A)Q2*B@G.(J+KH)F'[0\^/0+O-L
M*7<7:^.U>`[<>+@;(UYU>[VVUD;7C0LKHJ5]HMWV^%[DRP0>G&9>=P:T:-'J
M+FZ<!0Z:<`2CT?+>;L24S5-/K!,R3AP[K5CFNUCG$3/'KD7%-L$7:MC^WSD&
M5:>L&`7-=L["]8Y0='ZBHLI!HW(4@%`>/.-[B^0R$!H=2C1P``II\3SYJ\]&
MC4$FO+P4\GCY1+@B7!%R#[AOQ%^H_!%D7^^'X0^L>"+#P1+@B:IO5DZ1PMI5
MMIEJ&?,XZ=QWKCF:V5YX_E`A&B-CB<?3[BO"I+<C'CS'F@0*10@&4`XAT%,8
M0`2*L#[G%=0GN[_B;6OUB,DJIJ+A'4O7IFVC)9]/1""6',"56WW-J0RZ"2C5
M9;(DQ*&=D4(!A=G.HOR444`)-[08EF9[AX;'%K7,-XZ1P(J*-'5J#\.:PSN+
ME/Y/LG(9,D@_EW1@C0U<.D4/^MR3P'KYNP;*OGBH(((E*HJIR.H<#'.4J1$D
MTBG6<.%ECE(FFF4ZBJABD(4QC``^HES>VN)M[C,9"YBCP[(^IQH*L=TT)KR(
M'IKQ`T7G!B[#)9"^AQF.;[F:E8&L;QZFTT!\13D5(L[:^NW>=PK7853%S;%V
M*L#34B:?)A;;N7EW!(YO.*.Y&5GZ?1L=QLCD;%TE+.@!52/7E8UN99X=PM&>
M-XG5YO\`=[/=I\]=/O-DV-U#F@XETS:-LWFNI,#O67.X]0HTDU5\^VF$[BX.
MR99;KO;:XQ(C:!$T.-PS3Y1(.+6\`-:``!'79:PWVP*OLI3UII>#-E)%FQ!]
MD+6AA/MZM83MV8J*1F6Z;?7#F!S=$-Y(YBHKRC)G+(LS&*T=,5#B<(-H*&O,
M:J7_`-R9WW"-X<O:C:BYR6S!%1^/\GSU5D*)@G/.-7BSS$=MOEN&/K\6J2+G
M'3VYXFO,$UEG4H$?*D?Q1B1ISM9A=3DD'?[9Q%OF=P6&/F<6V#Y8Q*[PB+Q[
MCB?)E37]:ZS.WDN/Q%Q>P#JN&P/<QM.+@TEH^TC3Q0@,-S="5^7*WAIE/02;
M3M&OMM;WSG(*2+N3F+3D?%-PK]E=**"8Y@FJ7,1Y/%`QP75:J*&.8YCF&9=V
M8=FW/J!;CK1C66$61@%N&`-:Z`Q-+7T%!4BKB:<37B2HLP>6N,WV>ER=YU&_
M=:7`DZC4]37.#N.NE!0'@MT]]R^I4G$?;5F:]/-ZSE''D7,YCH]D,#9NXJCR
MD4;%9H>Q$E78I(,T"6]:/140,J0':9CD,`I@?EP>R&W,=NB\SF.RG2+,XIQ+
MB!Z#[C2US2>!J*`CQ/BN?W2S%_A+3%WV+#G7QRL=&"OXC>AP>"!Q'2ZI!J-!
MX(T.&]F<N;EXMH%WUH@XND8\OE-KLU(;&9+C%E8PTG(,4PM,=A;#97AI6XO8
M"4!RV\SGWD5"-71`!).7*FH08/N8'VEW-:O^2.5P:>9H3^G]"E2(B2%DWWWL
M!(\/LY?IXKTT]KEFG&+B9O.N$CAS(.;[%$A'6#+NW1K_`&&\R9UESF6:-;#C
MGRUC4J,S*W:J)5B`BHF*452,(@F<WB\;5`=#P_H7UT@FO!WBHU_=2P+W89I9
MIE#;PL+E_"F/9%U8(='59Q8%\,8G5:)O8]M<+5AMV@CDM:84C91;G.2);22*
M2.?^-,TP$1LYV-W)V?V_=1NS-O<1[CK2.>4]3.NHH&5^5QX@\:`J"NZ^"[FY
MK'RQX2XMI,-3U0-;TR/%"?4[@YH_LUIPT073MF<JR.U7!%Y'2;0[=<I1(JW=
ML'[<4E2D4()B*(.6JP\A`1*8IN8<PY<7UGC;G+9_5J^>W>!SJUS#K]HT/B%2
M2!]QB+UEW+6._M9VGTU!9Z@#2FH\#2B:KV4+<_Q1>^YMBB.BW4\\QKARI;95
M%"+0BW[QM=.W[M'CS*$.[CRRB\8Z<J!4I";062060\9HJOUB7D0Y/(?<-B[&
MYR[Q[N$-S(T>``<:`>2]1,9="_Q=K?4H9;=CC]K05;%M':4@T:OV_5X#]LW>
MH=8`!_!=HD<)=8`)@`WAJ!SY"(<_T\=,N:OHX(EP1<@^X;\1?J/P19%_OA^$
M/K'@BP\$2X(AX]V%!BY[=^T36319N8UU2X-K(MI%-!6/<1[F^U%%Z@_2<@9L
MJR6;',54J@"F9,1`WHY\$5<'N@`$^8IWA(3[*9,RY<*0I>0$*G['1Y2%*`<B
M@F!````/1R`.)T^FVG_=[&5_WO\`\;E$??3_`/,;SP]QG^-B)]IE?\68KW`U
MDR/FY)J&)Z;EN+F+=+/U`)$U%8(:=9U"]3:0LGX.H*E7IW%R+H.E,$$D/614
M(#<>=L_J!Q6?RO:F^M]O`F>WN+>6Z`%2;<ZT`&I\P/M58NQ]_A++N"V3-.#;
MS\N!$XZ-`H-*G0&E?-6#5)O]&R/$)3]`N-3O,$N@T71G:?9(6SQ;E)ZU2>-%
MB2$(]?-A3=M5BJI")P\1,P&#F`\^/-I]0XZ$"N@-1\-"K\`L?^(RE#J"/`^:
M]B("("`>@1`0#G]',0X^":`D:T"UI70\"HK>8=$=CNYMMKGG.&>+Z_UJU2P;
M>KMA;#:MMAFTI:GM+QD^;UZZ7.C5*T/F5,I=:R'8XV1>O;?*&65E&Y&J:#11
MD@DL,O;4[E6NP,&(]MV$;]UWHK)?2:MBC^];-;R]P5:7-UU].H"C;<.QI]X9
M83YR\<-OVM!'$PEO6_AUOZ=7`:`-IP&I%2A[Y*HF`Z_C'9_4/M`#L[LW%Y)@
MZR?<#)C]:GSFJ$!7,8I+VY>7@+.[K]*85V^D19*@W7B73*&<E/X8)R($2*G\
M19?*_P"8[7?'<"\%E%!,R5D?M!]P0`"T1VPZ0;<'0R$QM(^7W'U!WKC&V3L#
M<[8VO$Z:YEC=&9C(0UA=H29M:$?^V`X\N&JW*7'NKNYV7Z7C;NK7?9733N`4
MRCUG&>-X.\K4>NZSN:77E'+F!5P@A-5JR4-Z$V_5<@L[F99Q(/7H=#:26Z&R
M2778+(;DV/=29O94T=YCHS"72M`D-'@D%T1U90Z%U"!S/-<W,XS#[DMVXK<`
M<)R)8P*F(GY>JCZCW-!44(KX)_>@NNFU?;%W=KFO]EG5LO:<;91UW6JV1*E!
M3+2H57.%3KKNX1+VW55)2?:8INMUIE=?-W3A)X-?LXD;J)K%?MO`4W-][VP.
M_P"&#+OL68_>K!2YZ#^'<-Y/:!H'`ZD#B%Q]F[7RFT2_',OGW^U'ZVH>/Q(#
MKU,+CJ]A^[S;SXJ2;Q&50#3FL^&O!:GS!FG#^#ZC,7+,N1:1CRIPL4\F9F1N
M4]&12/DC3I1?*(,7BP/9@53KD0(V;(KK.5U2(ID.HH4AOH07-R1!9M<^[<0&
M``N/42.`&OCP6W)+#;L,DY#8`#U$D`4H3JJXZPN*H^MMTDJ#&.H.@R=ZO,I0
M(1ZR7BW4/1).X3<A2HQ:*=*KN8D[&KKM$_5%#BHU`O@F`#$$H>LG;ZQRV,V'
MB[+,U_F3;5E?[0&FAYU','5>;G<>]Q5_O#)7&&H<>7/U'`NTJ1RXUIXH=VA(
M&0[C^_*<4DS]9)HUW,3QR7V$F:LB?5R^JH$5\$0`J:KT.:H@//TF'Z>?'G%W
M?Z/^Y>;#*=/\QFX<.(\-%>OM@Z1W;[$&4N+_`,C'QK7GXZ\%;+XF5LBV,L>'
MN+=@TMIJ!2#VAK$G56B&MC/5XLTZWBG"IU#N8Y&3%4J)Q$3&2`HB(B//B-EG
MBV'P1+@BY!]PWXB_4?@BR+_?#\(?6/!%AX(EP1-*WWQ0OG32+;;#[.*8SDGD
M/77+U:@XN1C#3+1W8GE&FCULAXL@@J]5+/)-S)$3$%/%`HD$#``\$58YW,G9
M*KWG:+L&DQCZ[3=O<3ZO;#08QBTLWC)".SS@*KPMF>F<2J!73KKR0QE"K=10
M(99+I-T&`Y22?V;RPP?<C#9$N#6&\=&XDT`#AT\3\1_0L&[G8C^>=OLOCFBL
MGY02`#4DQGKT`UUZ?/BBH:<ZP2^XNR>-]>HZP.J=%V;SZPWNWQA&:DS7,=TM
M@G(VA>M(OBJ-E+3+*N&L;'F.DLFU7?>M*)J$;F(>\_?'?%[V[V0+O$U&5O+I
MT+7TT;Q=QX5Z?4`3PUX*FW:#9]COK<ABRM'XFR;[SHZZN-:?&G5H?U<5/(UP
MUGP/J?CB/Q3KUCRM8UI*"JKY2+@FB99&?G'/(9*S6N=6%6<N%JDSAS=2,@NX
M=*<@*)P(4A"^:5_?37MX;_)/ZKB1Q))->ISC73QK72BO]8V\$$#8K.ALVM`%
M/E:!H!S`I2E.7!,@VU[MV"=?K:A@C#\%-[?;;SJP1M=USP0L6QR;&34=HLN6
M1[=%MI:'H+1L983KIJ$<OTDR&.HW32ZEB\_'8B6Y'7.X6UN!4ODT%/)IH7FG
M(?!<*ZRL<(Z(&F>0Z`,U_617IY:GAQ0Z<S:\YGS+25=E>^5GB6PUK+"33;R3
M277-K<Y*C0#B2<&2KI,W7K&45:K):UA;)BBHJ0ZJ#9=0!\R9]0-^.TCRF,QT
MP@VA`9,L26?F9J`.ZM*1P/'M6Y)(H[UO;QZFD575_P`OO+N,OS[Q%CP`1#'4
MEI;0U?.T^[,WQ'X;'4H6.!H1N;W]R*BYTP9.:.]N3$K_`!9K&K7Y,MG2QM3%
M8;(F78YO&&D6T'`4:B-75BH-#,O&*.9B7DCDG9M%H)519M/63.);VQVPQ=K:
M2[H[HY>RMB(R^.!TC+J1S@*])$;G$UX`:DG[%@&:WUE[R^@P';_&7ES+[C1)
M.&/MH8VU`<ZLC6!Q`\J#E6JVSA'N<:SY:Q%$:8]X3%JN0X6E%85>I9NGZU9I
M+($(=HBM$,C9BK:0L\S4+)L>ETLAL=?0<#+C]IZ@@J*AE>JWEVYEV[>#=W;W
M(6LVW)H3)$Z*YCBE@BTZF21=8>"2:>V6U<V@Z2*KD[8WLW.Q?Y;W9C[FVSL,
MO28YH)',E.IJR;I,?@0>J@IH40+'V']^-"J96,I=OF^3V_FC4W`1]PC-5<\A
M/5;.]'HCH3RK9M@NT6./A99P!H5R?U>'?QS5P55)(@12ZZ@J<1H;_$;@D?\`
MS2W9898<;B(`,N'</5"RC(CK5TL?2'TH6:U6?QVN1Q32;:1US9N^ZZI=$.09
MS/A373FB3:9=SS6/=-\ZI53G9'&&=X!9^QN6MF869*3F>L2D0F8TPV2KCY;H
MLC6/\,YE%6!U544R]3E%N/,O'79+`Y#&AMQ,QLUF1Z9V^IHKP:7#@3X&A\ES
M;'(6UVQS(6^W(#ZF.%'U'/I.M//@MD[@Z*:U;OT]"N9QHT=,6"!(]''N3X8C
M:,RGBJ2>@0RDI1+@BBI(1Q#.D4E',>MX\7(`F";MNL3T<:87/9?;.4BS>!D,
M69MGAT;A2H=]OE7P^*TRF*QV;L9,=DVA]J\$$'@#PU4"/+6.K/@3)V4<19&6
M0&S8:NMFIEEEDD18L)9&M.#*LK4T36!,K:/LU;4:RJ1/01))V!0,)2]0^H_;
MS>G^;=D0;L+A^8,4CK@_VIVL(>[X4K4\N:\[^X6S1MG=,FV[?_ZD\C#&WGZG
M@#X^%>:8+V7ZO+Y,R=W-LU0R0M5+?@MCK+5#)H5<'!+OW`]G<:X/K[.'D[<[
M(TC9A:GOYTQ3D1<*"S3<B`<R@53R^W)>_P`QW!>WVE);F1P\P7&A'DO1#$69
MQV)M;`\8;>-A\BUH&OGHK9QFS1CF;2.;]8MX]JV8H"H8#*>"T1(W2$Y@`H&.
M)$PYCR#F/'2+L%]'!$N"+D'W#?B+]1^"+(O]\/PA]8\$6'@B7!%B7+UIB7H*
MH`B7J(8`,4Y.8=9#%'F!BG+S`0'Z0'@BK&?F#]1K!CS'\?-11A5M/;KV*N>N
MDZBV("LJWU#V:LTWLQHODAZX;@!6L#6Y&:M./P5Y]"4A#HH`"1A*4W(M+E]K
M<Q7#/FAD$C?[P-1^T!?+F-DBD8_A(SH/]WFMU=I;?ZH8.R9AC<.U1$S8:2TH
MF0*5EF(J[%M*6R*5FZR5O)KPL<ZD(M%V_8W.!CCF(=4G7'.E#A]`&"[/<9S^
M[?8W%[CV^_\`XZRF$EVQY](G`]E__EJX?PJI&RHX>W'=Z^P68:V/'WK70VI:
M-7L<?=;YFKO1I]_12:5*_P!SSNBJHN;*K9>V'I3)'!0U5@WJCC<W+T&LU6`5
MY:3!JR;XS@)KQRE\`PM3$*4PG1DDQ*8:E.?MO;0=[;6Y#,!VCG"N/%.1;3W9
M:?Q^W'_!(-39ET62RTS9I`;2(?<;I<$?W@>AM?`U->)!"*_J?HQJ_I/33TW7
M+&$7222*#0MIM:RBLYD&\NFR8@#^Z766%S.S2RBQU%?`\5-DBHJ<44$P-RXZ
M"ZR%Q?\`XUV_K;R_L@>`&@`'+3@NY@LK:R9^`WH',^)\SX^)3L7#9-R4Q5!.
M)3IF2.0!`2'2/]],Y#%,4Y#AZ#`(<A#T#QP3J.-//P\UO&E-14>'BFW;!5*J
M5?7+84:W!P=<6<X1R:+@(&)BX4[TJ-*G@1!T$:T:"X*EXANGJY@7J'ERYCQM
M22LFZ8Y'2N+3H=4:(V-ZX007<0MT$JE2DE8N;?0-??SR#2/!M..X>,=SC8[9
M$BC?U>67:J/T5&HG$R8E.`IB/,.0^GC<8ZC>EKI`P\CP/Q6A$74"YM7C@?#^
MI>I*W*5`41.J<IC")CJ*"=41,;J,(J"`CS'Z.?&I(:*GJIY<5N-J3HF`;F]M
M'5?=9LUFLD4^0JN6X59)S4<]8HD$Z'FFK/6Z!T6+AM<F#4RLZU8]0&2:RI'B
M"1@ZD?"4Z3E['%YG(8GJBMIC);N%'PR#J8YIXA[2#4?`=0^Z1Q'5W./M;^CY
M6.$X/I<TEKA3F""*TYBNHTU&A':YSWW(.U<0SC;J(<[]Z7PX-`>[3X]CVT#G
M_#=:(N1HO)9BHR@E;6Z/CVY2KKR)G)TRDZCK2Q1Y(AW#K;`YPUQ1;CLB!_L)
M'%\3B016&0U,=7$`12%SCRD=2@XC)<GCY1^;_P"-@-09&M#7L;Q]<8`!`H3U
M#I_N-YPY>ZYMXZNCG97/X(C6K!L?DJQMZ)!.E6Z$K!UN6;MJ]#$=$;%.0TM#
MXVA&RCXQ>92/EC!UC]@1N+FGY/LW]/EIC+IT<>;OK=S&L%!(U\[JOT\HB3\%
M5_#_`)'NQWL%[$!)A+$$ND_],>RZK*GSET`XGC3BB@_+::E3T)`ZG4R5BFZ3
MG*][E>Z#FTCEP*ZD?@[#D18L`:)UB0CR$,BTDLC9LM-JO#(JABG.PK"#C[0`
M0"43IT_AG5S3\PX$'73X%6^+BZCG?,=3\5/R^GT_[/\`?XT6B7!$N"+D'W#?
MB+]1^"+(O]\/PA]8\$6'@B7!$N"(%7>9U=JEJHL[L-:HAU)83EL1V'6G?B"A
M8,TY8)/4NVR9IZJYTK[1NFH[-<]),PK-K^T4(`&+7_/$^?VRAP15R<)`7_ME
M[8Y*T[V-6CW=(DI)D>,NK(1<4*WUNR,R.,?9LI,HIXC*9QKDNIN4E1<H'71\
M(W2814;JAQ8/L/W,BVAFYL%FVB;;&1A]J1CM6Q.X>[3]IH"?)0YW@V%)NO$Q
M9O"`LW-8NZHB-'.IR!X5/%NH_;13!-,>]YF[6S&\5BO*M"#9NEUN.;LL?7(]
M^/5LI1E>(9N$?7+!.RT-9(/($3$1PBG&R"RC22!N1))PLYY>.$A[R^E^7(7S
MLML:^B_+O'N>VZI:0_U#H=\IJ#7I'J'`@<%'VU^_]M;6[<)O:VE_/M_#,C`-
M7-T)>VH<PU''Y237P1%-0.[YFS=3>/$F&(F@4+!N%W%4RE:;3$/I9?(V2,@O
MZQ3`4A8)K9#M:C!U)FPFI#S$X,F$B[=(,.@QTDS*\HE[D=ELKVTV]%GLM=17
M3Y7](CB!TT)U)TY4^*DW8?=?$;ZSTN*PMK-##&RI,A&O+0`G3S\U(/FK#!UZ
M(E9V=FHF!A81@ZDI>;FW[6+A8A@S2,JY?RDH^508L&+4A>I5550B9"^DP@'$
M)BC@"""#X$']@U4K5U(X$>.B#]0=H9?=[&?<`SK3I)ZVU?QI1\MZ\8):I"B@
MTR])U['Q+)DO/4JU_,='B'LN_:1-1(<R)B1*+IVHB)GY/#YM]C+O&3?E[^-T
M5QT-=TN%#1PJTT\P5Q[>\M;Q@DM9&R1DN%6FHJTT<*C30Z%;<R]N!&Z>[BXC
MQ[G:SK1VOFW=-<!CG(MD<-DJYA?/%`&J0+S'DP_2BVY(:A9=@;(R>LGK]X=.
M-L#1R0YBMY`HMM;/&W^0CGELHG2LM8O<EZ=>AE0.HCB=2.`)U2>\M;5\<=P]
MK'S.Z65TZG4K0'A6@-*G7DB:KNDTR'$#!UEZ>1#%.',1Y&`O+I`WVB_1R^G]
M''6^XPQN>/5T@FE>DZ#SHM^3I:6LD:XM>0/2"=*^(J%&1R)WQLUZS[+[(8.R
M-B7'VP]+QCF*WU>E7"@6XV+[NT@D7<8_85NRL)"(ME.L<M5&LHM&NW:"D0<S
MN/$BB`G,HJ$_;5^G_=.]-G6>Z<'>68?<EU8I@\4#32O4UKAYCEYJ'=S=Y]M[
M4W'<;?S%K-[$(86N91P)<.8#@10\?BAI]P+O`9IW"HL]CY]!UW7C6SPVTK=J
MQ'V%>RV^\QL.FG(+1^2+ZLS@HEM22/VX+JP\9'D]=\(A'+I9$QVYYJV#].^,
MVE-_FK?=^U[[)IE]L`?EZMU!<[4N-*@-`U)!IHHMWEWOR&YFC;6RK>2MU1G5
M3\0AVE&4-&FM"7$_*#P*BW8;H9>YOMV_E+U*3=)TFUJKCO*N?;TFQ=G-3L"5
MB1:%FT8MLTY*/\Q9UG%&U<JT8@)WCN6DFI$R"DV6,2N7=[N*[N+N9]Y:MDAP
M%K^#:PN->B,<2[^)Q_4-.2G7MOLAFR-O,M9S&_-W/XMU(T4ZY3P`_A:-*<S5
MW-6=G:NU=E,*X5L66<B4-GCC+>SLI6KY)XV;`?E@3"=0J[&D:N:NM3'*0R:.
M!<+1K!E(E`.A6SO9=<#*>,*AXH4@HI/!$N")<$7(/N&_$7ZC\$61?[X?A#ZQ
MX(L/!$N")<$7RO63*2:.8^1:-9"/>MUV;Y@]02=,GK-TB=NZ:/&JQ3H.6KIN
MJ9-1,Y3$.0P@("`\$4';OA=HND(4FLXM?G:T7!K"<?!I9M[;7J\I$ZF7F[34
MH\5T,VDL2B:TG6=*,B6:6(KC&X*F5;8ZGG0Q#[HBUDCJ&N>QXD8>EP6E>D4`
MJ*J*?0LL9PT"RK8-/]X:%;L?2M%>M8WU.?0(\G*(B\32=L'*3EBL]9V[',LQ
M<$=1[Z-6=(&0,!VIU4#=(6>[,=][K:T;=J;E>^3`.-8IB"]]JX\7`#5X_A'#
MX*`>ZG9JVW3([.8-K8L\125M0UMRT<&=7!COXCQYE%6J5N;O?93(F/+>X;/(
MJ2C[71<@46?7CY:#G(Q0'$;.UFQQ"Z3N-EF*@B7F0Y3``G25*)3*)C=3)6&U
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M]QY=PW`+\3>VT/MR-;TQ5:T!P!X=0IHWB58?Z?LO97VQK;#VQ]N]M7R^XUSN
MHT<7%IZN?57]E.2USWY]F:)F;,N)M<Z5*QELC]?JY:GF673(6DE#L,FWUG!1
M;7'KIP"*B2\U6*C$++2[4JITVQI5NBL4%R*$3S+Z6-I3762R6?R5OU85UIT-
M<\>ASB16M?N^9TJL;^HG<XL;"RQ./E/\P,_6>@GJ8`#0]0X5/[."&33=U]R\
M=8W<8@H>TF:JSCA5J9@SK[6TH2#ZOQJB::*D54;C/1<O>ZC&`DGTI(QDHU(U
MZA]7\+F/$X9?L'VFR&1_FMW;`/+JEK7]$9KI2@TUKPYFBANP[V=Q;*P-C%>0
MM:&$-?*P%XTT]1TK7F04S&YW>F8OK;NT7>PM:]#-U'+ES(RSMR[>R<B[56>.
M3)F74<RD_.2KQ8ZBI@%9RX75,=01,8QN)`N\E@=@;>C>2W%8*Q`;&QS:F4.T
MZ0!K5_"JPK&X[<^^<H&LZ\AF[LN,TI]+6`<3U'TT`X(;46;/G=4S4RUVUWC6
M=(Q7")+VS)60;Y-H5;'>/Z#"+E\[S'GB[NQ2A:AC^M-A*HBV64$Z[DQ$$@</
M%44^*(=W^^&0W]=FPV\'6&V8Y.KV@=9'M!`<X\@03IYJZ?;'M-B]AVC;RX`G
MS3VZDZAE:$AI^.A//EYSD^T-VB\74JO8IL=:BY/X.\76.N9CQN3(%3&!R;O=
MLY76K]I7-ULO0LF<\A2L#XT2D%@PI1U4T5B%6-9)),SA=H88!)+CUGYCQ_K^
MU3`27'J/&GZ?IR4J?T_IYB/Z>?T\_P!//^'@M$N")<$2X(N0?<-^(OU'X(LB
M_P!\/PA]8\$6'@B7!$N")<$71V*KUFX0,S5;=78*UU>Q,'458:W98AA.P$]%
M/DQ2>QDU#RC=U'RL>\2,)545TU$U"^@P"'!%&/[BW8TJ>2Z*E48[&%@VIUQ@
MC&3Q]C%A>XRJ[HZ<QR[P7,H74#.>1'#V!R]B1NU4-X.([^Y)'L4T")0DFU_)
M;I:`O+3U:/Y47T>EWS*&G8^U/O#@BT7V:[>>1G6VM9HKV0-D3$-9@9"A;78P
M]2=>KGAL[:-9+*RR0A,M##T>8UIK8HAUTF5;/!3$!'--H[_W1LB\&0V_</AN
M^>O5$1S!A/I^WBL8W+L_;F[;(X[/6S)[3EI24'E24>H4_:F\L.XU;,?RKFG;
M!X.L-7M\,;U::9-$7]2L+)RD0P'3E*7<V[1['N3JE#F45R<@$W(OH`!LIM[Z
ML[NW%-PXJ"4_[OG\02*54"9OZ:L9(XOP%[)&!P;+4CR%6@FGV%;DB^XOK9+)
M"]<3.3:;)-"ND6,C'Q4Q#6%D63BG,5)J1%BI<YYE%^MQC]=FN*;A$R[=8Z9@
M,F<P#F64[Y=F]W8;^2YZ*\N+![O<,4T+`(9>0B<)7$L!TY?!8GB>SG=/:N0%
M[@;BR:\&M!,\!WD08Z$'S7QR7<;UIKS($80E\L0@FZ==#"M^JG4>JKG7<'?/
MK!)M5UY"2=+G66='\8ZJIS**F,<QN>]']1?:_;V,9C<%!=,MX6Z0LA8&24TZ
M7N,@H.=:'4+XE[%]R\W?RW^:N;3W9G>IQE>XLKS;2/EX:+5+7>_.6=;*ECK5
M#7BTW2Y3*Q&<&PB(">R9=G"BZ@)(G:4FH1KLGC&/Z`$YG*8<_3SY<QCG<'U7
M9N6.2#;&/MK?J%&OE:'EOGTZ@FG#70ZK.L']-NWX',GW!<R7,K=2QND;OB3Z
MO/@$[?%'9RV8SCDZ--OYD>XPUW<MV\DPTQP`:OYWWPFT7P&.SB#X>@I$V,-5
M8)=(R:KN>R1)P#..;#U&;KK%%$:T;BW5G]V7C[[<MW<7MTXU!>\AK/X6QBK0
M.6E."GS#;?PFWK1MCB+6&&`#B!1VG"OC7G4E36M#^R;3J+1JU"Y[Q7CO%.!*
MS8X>]T30?&]E?7VFSEX@SPDC7,P;T9C?,HV3VXSG`R44!F<49)''==$`(R8/
M3$3=ACY<'?<:#X@\OT^*[HGJ3V>\+O9=^W5I98LZXNJ%<LV2I>RQV.:4\NWK
MB>-J?/2]<M%D+:\@>6KL7BT*@TJ:S*/:)N&H/YQZP:"JD183!\K1-<['7=0S
M3W#X;--5V#J-2BLA8Q3KMSA;!18B4K+=>A7*V9"I<;5LET>:?R,G0,IPDUC1
MZX,T5.F#^(>M7)$4P`3*$1]>")<$2X(N0?<-^(OU'X(LB_WP_"'UCP18>")<
M$2X(EP1+@B_!*4P<C`!@_P``@`A_CX(FV[`:AZW[1$KJF<<0U&\3%/>$D:7=
M%$7]>R51)$GW9&A9.J3Z`R#2WY/O`I&R38PG*0P^DI1`B'[E[M#,\BM4XE+9
M.<R550=`8U'WHP5A'?.#:18L9&--"05TRC7:UGF&9$92B@(F"Z++(*")RGYG
M.!@T*(:>2/EPJW88J/?QFL':(L]UCF;"(.<<,[J8$K$PT157.\F7T7B7;&5C
MF\VMXG4!2L5>KGX8K%(FF`:.+G.K0`>2U)TH*+O\:?+E4JLPS<CS7/M+U.PS
M;F%4M+X-<-JMA6\"VC9(RSQ*DHYOVS)'*KOHXQDQ.NR:)F44`54U02)SUJ>`
M`HO@,'$N=7]B(WC7M#5V`AEZWD/93**])?KK'EL-ZI5#&/;^P?,,EWS]ZK#S
M,#JW6JME6?B%O7NE5"1NCLJW(XJ=7BG#@OI$=P;KE@?6BI'H^`\14#$M;<JI
M.I1C2*XPB'%ADDD00\ZM<N1,\U;K`LD'YTA)N7;Y<W,RBIC"(\$6ZN"+5^9,
M+XIV#QW8<2YMQU2\K8SMC=-M9:)D"O1UGK$RB@J1RU%W%R:"Z!7+)VD19NX(
M!%VRQ"J)'*<H#P1>1U[U8UUU2KDW4]<L,8]PW`V:9&Q65I1*^VB%K+.^`5J2
M6L<E^;*SSYNT(5%%1VNL*")033Z2>C@BW]P1+@B7!%R#[AOQ%^H_!%JG(V?<
M$XGEV4'E3->(\9S4C'%E8^'R#DFF4N5?Q9G+AH6291]DFHUVZCS.VRB0+$(9
M,5$S%Y]11`"+7WQGZ=_ULM9OZ><5_P`Z^"+MQVMU?+`%MP[(8""H&FS5D+8.
M9<<A6ALI6`2HUT)P;'Y6,\$68'(L_%]8]7_,Z.C[7!%U'QGZ=_ULM9OZ><5_
MSKX(N:>Y.H;A5)NUVJUK=.7"R3=!NAG?%BBRRRQRI(I))EM1CJ*JJG`I2E`3
M&$0``$?1P1;R<VJN-*^]M:\]!IUF+:/G\K8CS$<2`BF$6BJXDW\G-"Y\M8,(
MU!`YW"RJA4T2$,8X@`#P1:)#=#3L0`?BRUF](<_^WK%0_P",+7RX(NRAMM-6
M;+,Q=<J^RFOUGL4X]0C86O5[-&-YF>F9%T<J;:.B(>.LCF1DW[I0P%2103.H
MH80``$1X(O@/N7J$BJL@YVKUJ;KMU5$5D5<\8L(JDJD84U4E4S6HITU$E"B4
MQ3``@(<A]/!%Q^,_3O\`K9:S?T\XK_G7P1>EJNS6N-[DE(>C;`X.NDH@U.^7
MCJIES']A?H,4E$D57JK&(L+QTFU267(0R@D`@&.4!'F(!P1;P]`@4P"`E,4#
M%,`@)3%$`$#%,',#%$!^D/1P1:1N>R^N>.+$[J.0\_81H5I8)MEGU:NN6:#5
M;"R1>MTW;%5Y!SL^PE&R3UJJ55$QT@*HD8#E$2B`\$7F/C/T[_K9:S?T\XK_
M`)U\$2^,_3O^MEK-_3SBO^=?!%[8=@,&>P894#,V)1Q<+\8H,E>\JEA0!E`=
M@P\L"Y^=>S0R/KP@CX'K7B^+]CIZO1P1>)^,_3SES^+'6;^GK%?I_P!WVKX(
MMN4/)N.LJ0CBR8POM)R17VKY>+7G*!;("YPR4HV00<.(M65KDA),$I%!%RF<
MZ!E`4*10AA``,',B\):MH-:Z%/R%3ONPN#:-:XDR!92KW'+F/ZS8XT735%ZU
M\Q@YJPL9-B+EHX(JF"J11.D<IR\RF`1(L)-J]8#UIS<2;'X#/3FM@8U9S;BY
MDQP:LM[._C)"895Q>=+9!BT9YW$QKARDS,J#E5N@HJ4@IIG,!$R+N5]GS0KN
M2,'5VVAQ*]GLH4[&<I4Z7E6KW&UU2YU6#CO:B?BF#((N63KLFSC;#8G3XB,@
MP=I*+GY*`=/FF)%4Z]L36['.VW<<U-UFRR68'&.6LX0%.NJ%:?$A9AY7/&>.
MGS!E)E07-''DDF'@'63+XJ::AC)B4X%,!%:C2?R_':?E-7CZ?IZR%BL.'O!<
MGH)QF2,FIV]GE`*RE3`R&A;75M=R2MC&LHE9G!?QF2B0?;;F$1$2*J?P7K]C
MZW=RW$^K%H3EY7%EAW7IN`I\A'Y8Z?DZ&_S;'X^D?Y48MTRLIE[`'/S<(I$Z
M%S"<A2\@`"*R=O\`\I1V9[;79"%K6*LP8NF7`*^IV^G9UODK+QRPMW"*0DC<
M@/KG6G+=-=4BIB*,A,84BE`Y2B8#$4'#N`XBV]^7_P!U;UK-C/9"R6O&5]QF
M>6CF*[V13Q_FS`.54[%69JF9DQ(I+.ZN]5>FCI.+E$2E^V<GK;-5`RA#$(M)
M]V#$>HD12-`-HM/L6R.#ZKN9K3/9*R/B/VIL-LJ=*RW0\J6K&%\8T-[;EG]E
M9U8\_75P;-UWCE,B":8IB'4?F13$OEB>SOHG:=*-8^XMD'%KF_;2RM]OMTJ=
MQFK1:V<1C>3QIEF9K5+6JU3B)UC6UW\.>ED>`[>MG*JBSM4IP,F5,"D0H/FM
M^T]IIH?$ZRYWU.QLGB)QFJ[9/J.2J@QGK1.UN4D8B`KMA@K##-K1.3(UYRD=
M5Z1TBV$J+DSDA@`AD_M$6P_EF>RAV\^XYI9F+-FV^*K3D*_5K9"=QI!/(O*5
M]I$='5.*QSCNQMVJ4939J%07>*RMG='577%502]!2]`%'J(C6[#?)_=KC(E0
MF&^!GF;]9[Z:+(W@+'"9!ELH5EM(I+JK`]GZCD-S(RDRW<@H5)=%K,1WY:91
M3$BG48Q%%E';KN^?+4;D.=>LE9(G,MXF9F/987%][M%@M.",]8GF)$[=M>L;
MOIQ23F\933]:)41468"B\C)-!9N[1<)=0+D1I>^#@;MN]Q[M(7;ODX1IDJQS
MW(06'50NS2RS#=XO(-,A4O"5GQAE.EN7SZL.9.C,CJL2.&[5LX$6;=9-<Z"@
M^*1`S^6.[;.HO<PV8V+Q_MU0IN]5'&N"HVZU:(@;Q::("%C?7^'@%GSQ]3Y&
M(DWI4XUR<B:1UO!`QQ,)3&`HE(I=V<OE*>TE<,4WBMX=QKD7#^4Y*ORA*#D-
MEFC(EL+7;8DP<J0*\G6KO/S]?F8-63*D1ZW41354;"8$ED5.E0I$UCY>S36,
MV>[3>R/;6[BFO=_:4[%FU5A60J5UC[YC19]%3*,-9H6P4:?8L:J]<M(?(<-,
M*HO&;]\10Z@]?2B=(IR*%5WE^V?;NUQNW>L`N$Y26Q'/"-]UZO<@T$@V_$TV
MY/Y8W?NRIIH/+127I5868,4">(\9BX!--)PD7@BL8?E@+GJ/;>U%C)#5>GI4
M":@K#*1.S=17L[NS3[C8]E#0<5;;U)*R#QPLTC<CP<7&R44@BF@T:L#IM$RB
M=LJ82*+=WR,(X>[K7?'J^J?;OQXRG-B5R^R.X>=V,K.R=$=V^J-(>%EYBP-%
M';Z$A8O`-'KI(V5D&B;;S&4,2.`%7"2(J$4J9#Y;'MT-NW5*]OY"$O*<7-6N
MOY:E,XELLO[Q7FQ=9HUEH$#FM6(%\-6!*-B+;))$K96Q8<63LZ)BF6`KDI$?
M.[?]%+5_FO/?\U/>"*FW[$_]\_H'_K+0W_$3G!%<S$^^7\1?K#@BI7L"34-7
M.]+B6PV*7BX"OP7<RJ$Q.3LW(-(F&A8B-V=9/)&5EI1^LW8QL;'M$3JKKK*$
M212(8QS`4!'@BMPLA]RWMZXQJDQ>+EN_JE%5N#)X\F\1SKCJ<<ID,82D2:PU
M<GY:;DGJZG(B2#9NJLJ<0*0IC"`<$58CWO\`<;^VH[GR#[32BY!RK5(.E5+`
M^!8>N52PNK?DA&&DI>:F;F%..@I)0D;-6NU.B("LBU,G&MD%W8(G%0I2+UO?
M\T^LFA&'>T#JC=)$DG>,::8WN0O:B*B*S9A>LB9WN&1[A`,'+<`0=QM9L-J<
M1S9<O/QT6I5.8]?!%.<^5W_N0]/?^69X_P#,%DW@B$#\[K_X:M$_^_3*G_4&
M"X(M^?):?W:6?O\`7.M_^AS#7!%,$X(H5'SK>%*S.:>:J["*H-D+GCG8.1Q4
MS>`T$SR0JN4*%-V60CU'I5T^ELPF,;-UDR'35^VJ<2"3F?K(HWV@^:+-._+R
M=[/7V07=N:KCF[Z<9:K0+//%;1DED[-59J=D9,V9DNML1Z7'C%<X@H*8J`80
M(!C',8BW1\J7N]J=HIL[L[>MM<V5C!]4O.O\)5:I-6MO.N6TW8F^1HB7<QC(
ME?AIAQXJ,:V,J85"$*`!RYB/!$?_`+@G?MQWEC>_M-8*[9^X;FS57(FTE7@]
MK`QU!J)U*T42YY+Q?6(&D3[V\55O(B_=L0FA,6/*D9)LYZC*@8R7(BF9G$1,
M8!$1`!$`YB(^CG_#P1`!^8E[73?N/:(616@03=WLQKBC.Y<PE()1I7D[9FT=
M$KK7S#[=RGTN?5\BPK4!9H<Q2&;9,3"7T#P15I?;T[F>V?;<3V2K.N$PW@Y/
M9O&3K#=A:3*+L)&J607:S6LY&I[<R[="/R12CR<@U9*NDU$4PD%?$)UD3,0B
MLE?EZNSPS[9>MCC(N76J,IN=LC&0UDS7-+K(R;F@0"IO/H+#D5+=3DZPQ+IZ
M#JP.DECIRDR'/K41;-C`12'0^X;\1?J/P1=#=O\`HI:O\UY[_FI[P14V_8G_
M`+Y_0/\`UEH;_B)S@BN9B??+^(OUAP14F^.<;T[,G=SJ.(LB11YS'^4NX;&8
M[O$(F^>Q:DQ4+IL4G7;)%IR<8NUD8\[^'D5D@7;JIK)";J(8I@`0(I!WS*O8
M(Q3H%2\>;>Z+T.P5O7TCMMCO.%%<ST_>$L>6=^Y,2FY&;SUGDIBP-ZS<%7'E
M+M-PN=)I)D;=`@#SH(1$\^4`W@UDOF,;EIP]Q!A[%&W&.()>>:Y)J5/KU=N^
MRN)4I$ZB[NVV%LU3FK!=,:/'R35XF*HD<Q9VKKH,HF[.!$/;YVWE\7FE?3]W
MX:+3T_[7O0E>7^+@BE!_*[_W(>GO_+,\?^8+)O!$('YW7_PU:)_]^F5/^H,%
MP1;\^2T_NTL_?ZYUO_T.8:X(I@G!%#$^=5RQ4X71K6/"CUV;VYR!LR;(5?CD
MO"-SJN-,<6B%LDF[`5"JHI)RF2(]%+D4WB'.;Z.D>"*,KH#B>;BOE\N^%G)R
MD]1KMUN6E6*8<RK,I&+V4Q_FF`M\^NT?BX\199DE?F":J?A`0GC%$#F$3%(1
M.C^46U;UOVOVHVLJ.S."\69ZJ]6UY@[#6X#*]*@[O%04XIDN&C59:*93S-XB
MQ?JL'!T3*I@4YDS"41Y>C@BDA]Q/L1P#O=?M5[!=NC4'$F,H+`^S,#;]I%\;
M+T#$T*CC6K9"QG:Z_.NJJN\AAM<['(QTYX9F"+AX*0E1,42BETD4KPZR?I.)
MNDACB`&,`@`B(B`!S$/I$0X(@_=Z7NO4'M1ZE3&4ECQ=@SQD5&;INMV.'ICF
M]I+ZFS1]9M<T@3I/[!XY1?)2$N;J3%QS19IG*LY(8"*KDW@[?&Z.#,/8$WRV
MHJY8J$WTE\@Y!B5E&J\79XJRR4LK;C#D&N$B8^.J3[(\-+GL$&U0,<JT2)A$
M$3I&2*13\?E8^ZT;=?4HVJ66+*,EL;J'$0<`@]E')E)7).!#D")HEK]8>NU7
M\Q.TE1J$',J]/H(#!<XF.Z,($4K`/N&_$7ZC\$3"=V^XSI'I;#V2M;,;)XNQ
M->)'$UFO5<Q[9[*R9WNWUY-K8(QJXJ5944*_G5Y29AW#)HFB`F7=I"F7T@/!
M%4@]I#-.,->^Z;I?FW,-H;4/%=%S_6[!<;=*H/%F%9@W2C]F,M*D8H.G2,>Q
M4?IF<J`F8$$@.H;[)1'@BMGWG=Q[9;#%3C.:N\6NBN)&=U<XZ/?6>0XI]7EK
M^RK7MDO263QH98KZT&JX>N)LD0.NHB8HD*(F`!(JB_`F:\=UONF8BV,L<NO"
M8EA=[:9FN<L#R/=*.(C'++/#"\OYIW%,R.GQE&%9(9=1ND55;F02E`QN0"17
M#\'D/37N9ZY9-KV/[[C+:+77(K6S8@R&O2YEE9ZP\,]AV2L]77#]N(I-)V.C
MIQHZ3Y""S94Z*I>1BAR(JG3;O7?9KL%=SU!A4+%(Q=XPI=([+6N>6E6ZR<7E
M#%<J\D$:](2+%NJDD]CIN'(\@+3'%.!/64GS4#"D)%#D3DOF$>Z'A3NL6+1G
M.&+$)*!N%:ULE:OG''TE&OVHXYR:XODD_D*]'RBY#,)^$<I@+R.=-UE3&CUT
M/6`2<"HD0BEQ?+%=QK2.O]M7534&T[(XRJ.RT=D+)U`9X6M-B9P]]L5CNN6+
M-;*LC581PIZS8&4_'VML5JN@`D.X!5+[R9N"(2OS=W<"T[VQQOI]BG6K.^/\
MZV:A9$S!;[X?&EA96.-I+<D!7JO'1ME=,U!\OF):5,L+=`>9A29+&/T@*8G(
MMR?*<]R70_4S1S-V(-F=I\1X*R++;.6#($57,FV`U4&3J$IC?%]=8S$?*R;9
M&$>@K,0;M(R";DSE($!.=,J8E.)$;K97YH[M!X%JDO+TW8!_LA;FI9IM$8_P
MC2K0^=2DQ%(F*@W>7"W1%9I43"R3\R::<B#QRD9,3*I$6*7D8BA&9+A.Z+\S
M]O7[PZEB-_$8Y9MCU&D2LBUEXG7O7#$[9[(RB#*;R,K$@A8K(]=>*X?G;$<2
MDU)&Z$&Z39-%%L12'N\@Y[>G;$[%&2NT'C/.%0D]AHAOA1!_C09)B\RY;KO8
M\ETS,-PRC=()@FV5B(FP0\:NZ;KJD%)JQ,Q9D$W)+F1`T^56WYU$T)VJV9N&
MW&9(G"E2R!@".JU1GYN"MTW'2=@C\BP,RO$\ZI`V!VU=&C"'6(*R9$SE3.`&
MZ@`HD4Y?]XU[)P`)OCZQT8"@)A*%&S/U&`H<Q`O/&WI,/Z`^G@B`+VPN]97[
MKN%W6>X9M]M;?J'HW7Y!I1M6<-7ZXRLC7UYB;?3]GK5=Q?C%*028J93>8SQ0
M"I&;6,,JJM+K&.N!R+'.1#$TIRSC/Y@?O;L\\]P#+E%QSB*ARM:;:Z:FVRU-
MT9#(J*%F>+8KU_I;$&C%&S-E9!!>8N3P@%=2"ZI$`+X+DHMB*=/W?M<-8MEN
MWIL#BC:FYTK#F(PJK*6C<RW!VSA8#"N0(E^T:8PNH2*Z*B<2T96QTT8N")E+
MZW'NUF8<@7X(JE?0'='(G;1W0Q=LWBQRPL$QB^U/HNRP3&06-6LH8ZE5%Z_>
MZOZ^($`8NTP(G4CG*A!]6=D:N_#$4BE$BM:&O?;[7;W4J<W!:;6T%QCRMQE5
M-/UA)V)\H1%]NU0N5RJ.&']%!#S=OE6QLJ!-HM(XR?YQHMRJ4_@)&6X(M1=U
MC^P)]^&/_P"U@^'_`-^?NJ9>[_WL>\;S[W4>UUK]1]2]C?XAY/[8>;]'C?F^
M-XO_`*/+@B&";]S#YEY_!9SY!RZ??GR^D?O=/V>?^WP1.1']U7^$0G/X4?@_
M^)-;H_[7?8WXE?=<CXW+_P"<^T7NNZ/_`(/U;Z/S>")MP?N8?5_^%G/^'WY]
M/T?P_8X(I`7:Z_LT/AXL']EE[K_AV]Z=B]H?=3[3^SWO5\@JOM#ZW[6_RKYK
M[/>4]?+\GP?"Z/T\$3?.['_8@>:89_M:?AS]I/4+;[F?>Q[0^UWDGK47[6>5
M^Q/^4?LWYEZMU^M?Q'UOGX?YO7P1!_']S"Y!S^"WE^CE[].?^[R^U^O@BW]J
MS^ZA?$C@WX5?A+^)3WFU/W%^R?O@]I?>?YLA[(>2>;_R5YKYQX?J_K/Y7B]/
M/]'!%I>:_<U_.ICSOX+_`#KS62\X\?WW>-YKZXOYCXG1^5U^M]?W/L<_N^CE
MP1=63]S#Y?9^"OZ0^_[\N?Z/_:>G@B()KE^[`^%CKW"_V4_FG-S[!^;^Y/W@
M>L>)*>L>M^\O_+WS/_WGEYE_&?#Y=/V.C@B/A2?=][*5[W<>R7L-Y>W]E/8?
MRGV0\J\$/5/9[R#^1/4/5^7A^K?E]'W?1P11Z>XK^[3_`!77_P#M&_AF^+/R
MJC>\#WC>]+VO\J]CXCV&]?\`9;^2/"]C?4O!\+[7@='B?:X(F.__`,8/_P"E
M_P#]]N"+D7]S"]/+X+?T?>]^G^']'5P1.")^ZA?"JX\/X0/A8^(1IZWX?O4\
MF^('W;OO+_6NC_*GS+W<^M>K]?\`)WA^-X?Y_B<$6;4C]U-^)C"/PB?"C\3?
MO"@O<?[)>^'VF]XGC&\@\D\\_DCS'UC_`-5ZQ^5U\N?IY<$1YMZ_@^^%'+_Q
MX^QWPG>50/OA]O?._9+ROVOKWL_YQ[._RST>V7EW@^!]OUCH_1SX(HR0_N8?
M5Z?@LY_P>_/I_3^S]C@BW;#_`+IC\.F1/)OA&^''WW89]X_@>^'V:]]_L#GG
<W*^9]?\`*?G/L%[?>H^'_%O"];\3\WPN"+__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
